Table 1 Characteristics of study participants.
Characteristic | Result |
---|---|
Age, year, median (IQR) | 43 (39–54) |
Organ systems involved, n (%) | |
Lungs | 71 (94.67) |
Lymph nodes | 40 (53.33) |
Sarcoidosis activity, n (%) | |
Active | 43 (57.33) |
Non-active | 32 (42.67) |
Active Löfgren’s syndrome | 12 (16) |
Comorbidities, n (%) | |
Arterial hypertension | 7 (9.33) |
GERD | 2 (2.67) |
Rhinosinusitis | 1 (1.33) |
Cardiac arrhythmiaa | 1 (1.33) |
Hypothyroidismb | 3 (4) |
FEV1, %, median (IQR) | 90.12 (84.53–94.73) |
FVC, %, median (IQR) | 93 (86.13–97) |
FEV1/FVC, median (IQR) | 0.78 (0.76–0.8) |
TL,CO, %, median (IQR) | 94 (89–98) |